Abstract: Provided are peptide biomarkers for diagnosis of allergy, monitoring development of clinical tolerance in an allergic individual, and predicting whether an allergic subject is likely to develop clinical or natural tolerance over time. The invention also relates to diagnostic methods and diagnostic kits employing the peptide biomarkers.
Type:
Grant
Filed:
March 20, 2015
Date of Patent:
January 4, 2022
Assignees:
AllerGenis LLC, ICAHN School of Medicine at Mount Sinai
Inventors:
Robert C. Getts, James Kadushin, Hugh A. Sampson, Luda Bardina, Galina Grishina, Gustavo Gimenez, Jing Lin